鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/02/25 | 3,120 | 3,160 | 3,090 | 3,095 | +15 | +0.5% | 47,500 |
| 2021/02/24 | 3,010 | 3,130 | 2,997 | 3,080 | +75 | +2.5% | 81,300 |
| 2021/02/22 | 3,000 | 3,030 | 2,976 | 3,005 | -5 | -0.2% | 43,200 |
| 2021/02/19 | 2,981 | 3,010 | 2,981 | 3,010 | +10 | +0.3% | 39,900 |
| 2021/02/18 | 3,040 | 3,040 | 2,976 | 3,000 | -55 | -1.8% | 47,500 |
| 2021/02/17 | 3,010 | 3,060 | 3,010 | 3,055 | +25 | +0.8% | 16,600 |
| 2021/02/16 | 3,030 | 3,040 | 2,998 | 3,030 | -20 | -0.7% | 33,000 |
| 2021/02/15 | 3,050 | 3,055 | 3,025 | 3,050 | +15 | +0.5% | 23,600 |
| 2021/02/12 | 3,040 | 3,060 | 3,020 | 3,035 | -30 | -1% | 39,700 |
| 2021/02/10 | 3,105 | 3,115 | 3,045 | 3,065 | -65 | -2.1% | 51,800 |
| 2021/02/09 | 3,175 | 3,175 | 3,085 | 3,130 | -45 | -1.4% | 82,100 |
| 2021/02/08 | 3,155 | 3,185 | 3,130 | 3,175 | +35 | +1.1% | 27,700 |
| 2021/02/05 | 3,185 | 3,200 | 3,060 | 3,140 | -75 | -2.3% | 56,800 |
| 2021/02/04 | 3,195 | 3,255 | 3,195 | 3,215 | +25 | +0.8% | 22,500 |
| 2021/02/03 | 3,210 | 3,220 | 3,185 | 3,190 | -35 | -1.1% | 21,900 |
| 2021/02/02 | 3,240 | 3,280 | 3,205 | 3,225 | -30 | -0.9% | 32,100 |
| 2021/02/01 | 3,230 | 3,305 | 3,230 | 3,255 | +30 | +0.9% | 34,200 |
| 2021/01/29 | 3,275 | 3,320 | 3,225 | 3,225 | -50 | -1.5% | 31,800 |
| 2021/01/28 | 3,235 | 3,285 | 3,215 | 3,275 | ±0 | ±0% | 26,800 |
| 2021/01/27 | 3,215 | 3,290 | 3,210 | 3,275 | +85 | +2.7% | 20,100 |
| 2021/01/26 | 3,240 | 3,240 | 3,190 | 3,190 | -80 | -2.4% | 20,600 |
| 2021/01/25 | 3,260 | 3,280 | 3,245 | 3,270 | +95 | +3% | 23,300 |
| 2021/01/22 | 3,195 | 3,200 | 3,170 | 3,175 | -50 | -1.6% | 25,400 |
| 2021/01/21 | 3,210 | 3,245 | 3,210 | 3,225 | +10 | +0.3% | 14,900 |
| 2021/01/20 | 3,200 | 3,230 | 3,185 | 3,215 | +5 | +0.2% | 13,800 |
| 2021/01/19 | 3,300 | 3,300 | 3,210 | 3,210 | -85 | -2.6% | 21,300 |
| 2021/01/18 | 3,360 | 3,360 | 3,285 | 3,295 | -35 | -1.1% | 14,000 |
| 2021/01/15 | 3,300 | 3,370 | 3,285 | 3,330 | +50 | +1.5% | 38,900 |
| 2021/01/14 | 3,225 | 3,280 | 3,210 | 3,280 | +55 | +1.7% | 22,300 |
| 2021/01/13 | 3,180 | 3,245 | 3,165 | 3,225 | +55 | +1.7% | 34,400 |
| 2021/01/12 | 3,200 | 3,205 | 3,120 | 3,170 | -100 | -3.1% | 44,200 |
| 2021/01/08 | 3,205 | 3,280 | 3,155 | 3,270 | +65 | +2% | 37,500 |
| 2021/01/07 | 3,255 | 3,285 | 3,200 | 3,205 | -25 | -0.8% | 28,000 |
| 2021/01/06 | 3,225 | 3,235 | 3,200 | 3,230 | +10 | +0.3% | 22,600 |
| 2021/01/05 | 3,225 | 3,235 | 3,200 | 3,220 | -5 | -0.2% | 15,500 |
| 2021/01/04 | 3,230 | 3,240 | 3,140 | 3,225 | +5 | +0.2% | 26,500 |
| 2020/12/30 | 3,215 | 3,250 | 3,200 | 3,220 | -20 | -0.6% | 20,000 |
| 2020/12/29 | 3,200 | 3,245 | 3,180 | 3,240 | +25 | +0.8% | 25,100 |
| 2020/12/28 | 3,200 | 3,225 | 3,180 | 3,215 | +15 | +0.5% | 31,600 |
| 2020/12/25 | 3,200 | 3,220 | 3,195 | 3,200 | -20 | -0.6% | 25,200 |
| 2020/12/24 | 3,210 | 3,230 | 3,190 | 3,220 | +15 | +0.5% | 20,600 |
| 2020/12/23 | 3,220 | 3,225 | 3,175 | 3,205 | +10 | +0.3% | 22,500 |
| 2020/12/22 | 3,270 | 3,285 | 3,180 | 3,195 | -55 | -1.7% | 42,300 |
| 2020/12/21 | 3,325 | 3,390 | 3,250 | 3,250 | -100 | -3% | 35,600 |
| 2020/12/18 | 3,220 | 3,385 | 3,220 | 3,350 | -10 | -0.3% | 44,000 |
| 2020/12/17 | 3,360 | 3,395 | 3,350 | 3,360 | +10 | +0.3% | 25,800 |
| 2020/12/16 | 3,390 | 3,395 | 3,350 | 3,350 | +10 | +0.3% | 20,200 |
| 2020/12/15 | 3,360 | 3,405 | 3,340 | 3,340 | -60 | -1.8% | 15,600 |
| 2020/12/14 | 3,330 | 3,415 | 3,315 | 3,400 | +85 | +2.6% | 44,100 |
| 2020/12/11 | 3,310 | 3,340 | 3,295 | 3,315 | -10 | -0.3% | 22,600 |
1101～
1150
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| キッセイ薬 | 428,500円 | +3.6% | - | 2.80% | 14.44倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| ペプチド | 152,100円 | +5.0% | +1.5% | 0.00% | 13.01倍 | 3.66倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サンバイオ | 244,200円 | - | - | 0.00% | - | 113.10倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 387,300円 | -6.4% | -71.8% | 4.91% | 43.13倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
